Brugia malayi L3 molt to the L4 stage in serum-free cultures supplemented with arachidonic, linoleic, or linolenic acids and the basidiomycetous yeast Rhodotorula minuta. These fatty acids are capable of entering the eicosanoid pathway of arachidonate metabolism, the pathway responsible for generating a number of biologically active mediators, including prostaglandins, leukotrienes, and lipoxins. To determine whether this pathway was required for L3 development, we added dual inhibitors of cyclooxygenase and lipoxygenase to in vitro cultures containing B. malayi L3. These compounds significantly inhibited L3 molting. To evaluate whether 1 or both of these pathways of arachidonate metabolism were involved in molting, we tested drugs inhibiting either cyclooxygenase or lipoxygenase. Lipoxygenase inhibitors blocked L3 molting, whereas cyclooxygenase inhibitors did not. To assess whether enzymes operating downstream of lipoxygenase were also involved in L3 molting, we added inhibitors of enzymes involved in leukotriene synthesis and found they were also capable of preventing development. We tested the same inhibitor panel on Dirofilaria immitis L3. A single lipoxygenase inhibitor and inhibitors of 2 different enzymes operating downstream of lipoxygenase disrupted D. immitis development. These results demonstrate that a lipoxygenase pathway product is required for molting of the infective stage larvae of filarial parasites.
Skip Nav Destination
Article navigation
April 2001
BIOCHEMISTRY-PHYSIOLOGY|
April 01 2001
INHIBITORS OF THE LIPOXYGENASE PATHWAY BLOCK DEVELOPMENT OF BRUGIA MALAYI L3 IN VITRO
Heidi L. Smith;
Heidi L. Smith
Department of Pathology, University of Connecticut Health Center, 263 Farmington Avenue, Farmington, Connecticut 06032
Search for other works by this author on:
T. V. Rajan
T. V. Rajan
Department of Pathology, University of Connecticut Health Center, 263 Farmington Avenue, Farmington, Connecticut 06032
*To whom correspondence should be addressed. Department of Pathology, University of Connecticut Health Center, Farmington, Connecticut 06032.
Search for other works by this author on:
J Parasitol (2001) 87 (2): 242–249.
Citation
Heidi L. Smith, T. V. Rajan; INHIBITORS OF THE LIPOXYGENASE PATHWAY BLOCK DEVELOPMENT OF BRUGIA MALAYI L3 IN VITRO. J Parasitol 1 April 2001; 87 (2): 242–249. doi: https://doi.org/10.1645/0022-3395(2001)087[0242:IOTLPB]2.0.CO;2
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionCiting articles via
SEROPREVALENCE OF TOXOPLASMA GONDII AND ASSOCIATED RISK FACTORS IN ONE-HUMPED CAMELS (CAMELUS DROMEDARIUS) IN QATAR
Sonia Boughattas, Hashim Alhussain, Ahmed Gawish, Nahla O. Eltai
SCOLICIDAL POTENCY OF BILE AGAINST ECHINOCOCCUS GRANULOSUS
İsa Caner Aydın, Noyan İlhan, Ahmet Şeker, Cem Batuhan Ofluoğlu, Fırat Mülküt, Nuri Emrah Göret, Kenan Çetin, Erdal Polat, Gökhan Aygün, Hasan Fehmi Kücük
SYNONYMIZATION OF PLACOBDELLA PICTA (VERRILL, 1872) (HIRUDINEA: GLOSSIPHONIIDAE) WITH DESCRIPTIONS OF TWO NEW SPECIES REVEALED BY MOLECULAR SPECIES DELIMITATION
Anna J. Phillips, Dennis J. Richardson, Charlotte I. Hammond, Brett C. Gonzalez, Eric A. Lazo-Wasem, William E. Moser
A RE-EVALUATION OF ZYGOCOTYLE (DIGENEA, PARAMPHISTOMOIDEA) BASED ON NEW GENETIC DATA SUPPORTS ITS SYNONYMIZATION WITH WARDIUS
Tyler J. Achatz, Dawn W. Cleveland, Sarah A. Orlofske, Robert C. Jadin, Jason Block, Lisa K. Belden, Hudson A. Pinto, Vasyl V. Tkach
DESCRIPTION OF A NEW SPECIES OF GYRINICOLA YAMAGUTI, 1938, FROM THE MONTEZUMA FROG, RANA MONTEZUMAE, IN THE TRANSITION ZONE BETWEEN THE NEARCTIC AND NEOTROPICS
Matthew A. Walker, Rogelio Aguilar-Aguilar, Virginia León-Règagnon, F. Agustín Jiménez